肺俞穴、合谷穴、定喘穴三穴注射川芎嗪治疗肺络郁滞型慢阻肺的临床效果分析  

Clinical effect analysis of Feishu acupoint, Hegu acupoint, Dingchuan acupoint injection of ligustrazine in the treatment of chronic obstructive pulmonary disease of lung collaterals stasis type

作　　者：王春文[1] 

机构地区：[1]邹平县人民医院急救中心,256200

出　　处：《中国实用医药》2017年第21期104-106,共3页China Practical Medicine

摘　　要：目的探讨肺络郁滞型慢性阻塞性肺疾病(慢阻肺)肺俞穴、合谷穴、定喘穴三穴注射川芎嗪的临床效果。方法 98例肺络郁滞型慢阻肺患者,随机分为常规组和研究组,各49例。常规组患者给予西药常规治疗,研究组患者在常规组基础上给予肺俞穴、合谷穴、定喘穴三穴注射川芎嗪治疗。比较两组患者治疗前后肺功能和中医证候积分变化情况,治疗后评价两组患者的临床治疗效果。结果治疗后,常规组患者的动脉血氧分压(Pa O2)、动脉血二氧化碳分压(Pa CO2)、用力肺活量(FVC),研究组患者的Pa O2、Pa CO2、第一秒用力呼气容积(FEV1)/FVC比值(FEV1%)、FVC均较本组治疗前改善,且研究组患者治疗后的Pa O2、Pa CO2、FEV1%、FVC均优于常规组,差异均具有统计学意义(P<0.05)。治疗后,两组患者的中医证候积分均较本组治疗前降低,且研究组低于常规组,差异均具有统计学意义(P<0.05)。研究组总有效率为93.88%,高于常规组的77.55%,差异具有统计学意义(P<0.05)。结论肺俞穴、合谷穴、定喘穴三穴注射川芎嗪治疗肺络郁滞型慢阻肺能够有效提高临床治疗效果,改善患者肺功能与中医证候积分,值得临床重视与应用。Objective To investigate the clinical effect of Feishu acupoint, Hegu acupoint, Dingchuan acupoint injection of ligustrazine in the treatment of chronic obstructive pulmonary disease of lung collaterals stasis type. Methods A total of 98 patients with chronic obstructive pulmonary disease of lung collaterals stasis type were randomly divided into conventional group and research group, with 49 cases in each group. The conventional group received western medicine routine treatment, and the research group also received Feishu acupoint, Hegu acupoint, Dingchuan acupoint injection of ligustrazine for treatment. Comparison were made on changes of pulmonary function and traditional Chinese medicine syndromes integral evaluated before and after treatment, and evaluation was made on clinical therapeutic effect after treatment in two groups. Results After treatment, the conventionM group bad better arterial partial pressure of oxygen （PaO2）, arterial carbon dioxide pressure （PaCO2）, and forced vital capacity （FVC） than those of before treatment. The research group had better PaO2, PaCO2, forced expiratory volume in 1 second （FEV1）/FVC ratio （FEVI%） and FVC than those of before treatment. The research group had better PaO2, PaCO2, FEVI% and FVC after treatment than the conventional group, an their difference had statistical significance （P〈0.05）. After treatment, both groups had lower traditional Chinese medicine syndromes integral than those before treatment, and the research group was lower than the conventional group. Their difference had statistical significance （P〈0.05）. The research group had higher total effective rate as 93.88% than 77.55% in the conventional group, and the difference had statistical significance （P〈0.05）. Conclusion Feishu acupoint, Hegu acupoint, Dingchuan acupoint injection of ligustrazine can effectively improve clinical therapeutic effect, pulmonary function and traditional Chinese medicine syndromes integral in the treatment of chronic obstructive pulmonar

关 键 词：慢性阻塞性肺疾病 肺络郁滞型 川芎嗪 穴位注射 

分 类 号：R259[医药卫生—中西医结合]